Skip to main content
. 2021 Dec 17;23(2):51. doi: 10.3892/ol.2021.13169

Figure 6.

Figure 6.

TIGIT expression in natural killer and γδ T cells. (A) FMS-like tyrosine kinase 3 inhibitor (quizartinib) did not change TIGIT surface expression in KHYG-1 cells. (B) TIGIT surface expression in γδ T cells (CD3+ Vδ2+). Left, separation of γδ T cells; right, TIGIT expression of isolated γδ T cells. FSC, forward scatter; TCR, T cell receptor; TIGIT, T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain.